JP5848756B2 - カルシウムｈｍｂおよび可溶性タンパク質を含む実質的に清澄な栄養液体 - Google Patents

カルシウムｈｍｂおよび可溶性タンパク質を含む実質的に清澄な栄養液体 Download PDF

Info

Publication number
JP5848756B2
JP5848756B2 JP2013514238A JP2013514238A JP5848756B2 JP 5848756 B2 JP5848756 B2 JP 5848756B2 JP 2013514238 A JP2013514238 A JP 2013514238A JP 2013514238 A JP2013514238 A JP 2013514238A JP 5848756 B2 JP5848756 B2 JP 5848756B2
Authority
JP
Japan
Prior art keywords
protein
nutrient liquid
calcium
beta
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2013514238A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013528060A (ja
JP2013528060A5 (https=
Inventor
デビル，ノーマネラ・テイー
ジヨンズ，ポール・ダブリユ
メイザー，テレンス・ビー
ロウ，ケリー・ジエイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of JP2013528060A publication Critical patent/JP2013528060A/ja
Publication of JP2013528060A5 publication Critical patent/JP2013528060A5/ja
Application granted granted Critical
Publication of JP5848756B2 publication Critical patent/JP5848756B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2013514238A 2010-06-10 2011-06-03 カルシウムｈｍｂおよび可溶性タンパク質を含む実質的に清澄な栄養液体 Expired - Fee Related JP5848756B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35340010P 2010-06-10 2010-06-10
US61/353,400 2010-06-10
PCT/US2011/039170 WO2011156238A1 (en) 2010-06-10 2011-06-03 Substantially clear nutritional liquids comprising calcium hmb and soluble protein

Publications (3)

Publication Number Publication Date
JP2013528060A JP2013528060A (ja) 2013-07-08
JP2013528060A5 JP2013528060A5 (https=) 2014-07-17
JP5848756B2 true JP5848756B2 (ja) 2016-01-27

Family

ID=44280787

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013514238A Expired - Fee Related JP5848756B2 (ja) 2010-06-10 2011-06-03 カルシウムｈｍｂおよび可溶性タンパク質を含む実質的に清澄な栄養液体

Country Status (13)

Country Link
US (1) US9521859B2 (https=)
EP (1) EP2442676B1 (https=)
JP (1) JP5848756B2 (https=)
CN (1) CN103096736B (https=)
AR (1) AR081872A1 (https=)
BR (1) BR112012031183A2 (https=)
CA (1) CA2801339C (https=)
ES (1) ES2535389T3 (https=)
MX (1) MX2012014346A (https=)
PH (1) PH12012502318A1 (https=)
SG (1) SG185806A1 (https=)
TW (1) TWI526161B (https=)
WO (1) WO2011156238A1 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
ES2548432T3 (es) 2005-12-19 2015-10-16 Abbott Laboratories Uso de beta-hidroxi-beta-metilbutirato para modular el desequilibrio en la producción de citoquinas de tipo 1 y tipo 2
BR112012018174A2 (pt) 2010-01-29 2019-08-27 Abbott Lab líquidos nutricionais embalados assepticamente compreendendo hmb.
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
JP5892948B2 (ja) 2010-01-29 2016-03-23 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ カルシウムｈｍｂを含む栄養エマルジョン
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液
WO2013067485A1 (en) 2011-11-03 2013-05-10 University Of Florida Research Foundation, Inc. Nutritional supplement for weight management
JP5878361B2 (ja) * 2011-12-20 2016-03-08 テルモ株式会社 栄養強化用粉末食品
WO2013170189A1 (en) * 2012-05-11 2013-11-14 Abbott Laboratories Combination of beta - hydroxy - beta - methylbutyrate and beta - alanine for increasing muscle blood flow
EP2897472A1 (en) * 2012-09-21 2015-07-29 Abbott Laboratories Nutritional compositions including calcium beta-hydroxy-beta-methylbutyrate, protein and low levels of electrolytes
ES2694426T3 (es) 2012-10-04 2018-12-20 Abbott Laboratories Procedimientos para mejorar el efecto de EGCg en la mitigación de la pérdida de músculo esquelético
EP3235387A1 (en) * 2012-10-04 2017-10-25 Abbott Laboratories Shelf-stable, clear liquid nutritional compositions comprising epigallocatechin gallate (egcg) and methods for preparing the same
US20140272000A1 (en) * 2013-03-14 2014-09-18 Metabolic Technologies, Inc. Liquids and Foodstuffs Containing beta-hydroxy-beta-methylbutyrate (HMB) in the Free Acid Form and Methods of Manufacturing or Producing the Same
EP2993994A4 (en) * 2013-03-14 2016-11-23 Metabolic Technologies Inc LIQUIDS AND FOODS WITH BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) IN A FREE ACID FORM
SG11201507133PA (en) * 2013-03-15 2015-10-29 Abbott Lab Low calorie infant formula containing beta-hydroxy-beta-methylbutyric acid
MX2015013179A (es) * 2013-03-15 2016-04-20 Abbott Lab Formula infantil con bajo contenido calorico que contiene acido beta-hidroxi-beta-metilbutirico.
WO2014144048A1 (en) * 2013-03-15 2014-09-18 Abbott Laboratories Nutritional compositions including calcium beta-hydroxy-beta-methylbutyrate, casein phosphopeptide, and protein
DE102013104897A1 (de) * 2013-05-13 2014-11-13 Gelita Ag Wirkstoff zur Behandlung von Sarkopenie
US10513555B2 (en) 2013-07-04 2019-12-24 Prothena Biosciences Limited Antibody formulations and methods
EP3082467A1 (en) * 2013-12-19 2016-10-26 Abbott Laboratories Translucent, high acid, low viscosity, high caloric density nutritional composition
JP6309287B2 (ja) * 2014-01-29 2018-04-11 協和発酵バイオ株式会社 ３−ヒドロキシ−３−メチル酪酸カルシウム含有飲料
CN118844612A (zh) * 2014-03-14 2024-10-29 代谢科技有限公司 含有游离酸形式的β-羟基-β-甲基丁酸盐(HMB)的液体和食品
US20160227828A1 (en) * 2015-02-05 2016-08-11 Abbott Laboratories Substantially clear nutritional liquids having improved sensory characteristics
SG11201806286VA (en) * 2016-02-05 2018-08-30 Abbott Lab Whey protein based liquid nutritional composition
CN106307553A (zh) * 2016-08-11 2017-01-11 广州白云山汉方现代药业有限公司 一种含hmb的大豆肽蛋白质粉及其制备方法
US9930906B1 (en) * 2017-05-05 2018-04-03 Swallow Solutions, LLC Protein beverages
CN107596356A (zh) * 2017-11-09 2018-01-19 江苏江大五棵松生物科技有限公司 一种可增加骨密度的复合胶原肽粉
WO2019158541A1 (en) * 2018-02-14 2019-08-22 Frieslandcampina Nederland B.V. Nutritional compositions for musculoskeletal support for athletes
JP7594356B2 (ja) * 2019-10-30 2024-12-04 小林製薬株式会社 経口組成物
MX2022011112A (es) * 2020-03-12 2022-10-07 Abbott Lab Metodos para tratar la diarrea o afecciones inflamatorias del intestino.
EP4326091A1 (en) * 2021-04-19 2024-02-28 Abbott Laboratories High protein liquid nutritional compositions
DE202023107635U1 (de) * 2023-12-22 2024-02-08 RenaCare NEPHROMED GmbH Zusammensetzung zur Eiweißsubstitution

Family Cites Families (153)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3105763A (en) 1960-03-22 1963-10-01 Beatrice Foods Co Concentrated milk
US3408210A (en) 1965-06-14 1968-10-29 Wilbert A. Heyman Dehydration of foods
US3542560A (en) 1967-12-06 1970-11-24 American Home Prod Infant formula with fat composition like human milk
GB1446965A (en) 1974-02-14 1976-08-18 Agricultural Vegetable Prod Preparation of food products
US4104290A (en) 1975-02-07 1978-08-01 H.L.S. Ltd., Industrial Engineering Company Process for separating oils and fats into liquid and solid fractions
US5219735A (en) 1980-02-01 1993-06-15 Institut National De La Recherche Agronomique Non-phosphorylated peptides from casein-based material
US4311645A (en) 1980-03-24 1982-01-19 Hoffmann-La Roche Inc. Synthesis of SRS-active compounds
US4742081A (en) 1986-01-06 1988-05-03 Alfred Stracher Carnitine coupled pharmaceutical agents
DE68904874T2 (de) 1988-10-31 1993-07-15 Sandoz Nutrition Ltd Organische verbindungen.
US5000975A (en) 1988-12-29 1991-03-19 American Home Products Corporation Randomized palm oil fat composition for infant formulas
CA2010511A1 (en) 1989-03-01 1990-09-01 Roberto L. Ceriani Method of enhancing cancer therapy by administration of unsaturated fatty acids
US5457130A (en) 1989-03-20 1995-10-10 Cancer Research Campaign Technology Limited Eicosapentaenoic acid used to treat cachexia
US5157022A (en) 1989-11-22 1992-10-20 Adrian Barbul Method for reducing blood cholesterol using arginine
US5087472A (en) 1990-01-30 1992-02-11 Iowa State University Research Foundation, Inc. Feed compositions for domestics animals containing hydroxymethylbutyrate
US5028440A (en) 1990-01-30 1991-07-02 Iowa State University Research Foundation, Inc. Method of raising meat producing animals to increase lean tissue development
US4992470A (en) 1990-02-08 1991-02-12 Iowa State University Research Foundation, Inc. Method of enhancing immune response of mammals
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
US5167957A (en) 1990-09-06 1992-12-01 Virginia Tech Intellectual Properties, Inc. Compositions and methods for the treatment of dietary deficiencies
US5601860A (en) 1990-11-30 1997-02-11 American Home Products Corporation Corandomized fat compositions for infant formulas
ES2157898T3 (es) 1991-01-24 2001-09-01 Martek Corp Aceites microbianos y usos de los mismos.
FR2674102B1 (fr) 1991-03-18 1994-05-20 Meiji Seika Kaisha Ltd Aliment pour porcs et methode d'elevage des porcs utilisant cet aliment.
US5171442A (en) 1991-10-18 1992-12-15 Nakshbendi Ghassan F Water purification apparatus
US5223285A (en) 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
FI951218A0 (fi) 1992-09-16 1995-03-15 Univ Iowa State Res Found Inc Menetelmä kokonaiskolesterolin ja matalatiheyksisen lipoproteiinikolestrolin pitoisuuksien pienentämiseksi veressä
US5447732A (en) 1992-11-25 1995-09-05 Ajinomoto Co., Inc. High-absorption mineral-containing composition and foods
US5348979A (en) 1992-12-23 1994-09-20 Iowa State University Research Foundation Inc. Method of promoting nitrogen retention in humans
WO1994026855A1 (en) 1993-05-13 1994-11-24 Loders-Croklaan Human milk fat replacers from interesterified blends of triglycerides
US6136858A (en) 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
US5952314A (en) 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
US5780451A (en) 1994-04-01 1998-07-14 Abbott Laboratories Nutritional product for a person having ulcerative colitis
US5444054A (en) 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5576287A (en) 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
US5726146A (en) 1994-12-06 1998-03-10 Natural Supplement Association, Incorporated Non-steroidal, anabolic dietary supplement and method to increase lean mass without linked increase fat mass
KR0140248B1 (ko) * 1995-03-23 1998-06-15 한상기 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법
US6099871A (en) 1995-06-01 2000-08-08 Bristol-Myers Squibb Company Anti-regurgitation infant formula
DE19528461A1 (de) 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
US5641531A (en) * 1995-09-28 1997-06-24 Abbott Laboratories Nutritional liquid supplement beverage and method of making same
EP1006806B1 (en) 1996-04-11 2006-09-13 Loders Croklaan B.V. Free flowing fat compositions
US6077828A (en) 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US5756469A (en) 1996-07-26 1998-05-26 Beale; Paxton K. Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal
US7504376B2 (en) 1996-08-12 2009-03-17 Natural Alternatives International Methods and compositions for increasing the anaerobic working capacity in tissues
JP2001516343A (ja) 1997-02-21 2001-09-25 アボツト・ラボラトリーズ 壊死性全腸炎の発生を減少させるための方法及び組成物
US6080788A (en) 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
DE29707308U1 (de) 1997-04-23 1997-06-26 Kunz, Armin, 66450 Bexbach Präparat zur Muskelerhaltung bzw. zur Förderung des Muskelaufbaus
US6660258B1 (en) 1997-05-09 2003-12-09 Pharma Pacific Pty Ltd Oromucosal cytokine compositions and uses thereof
US6371319B2 (en) 1997-09-22 2002-04-16 Abbott Laboratories Closure system for containers
US6096358A (en) 1997-10-08 2000-08-01 Abbott Laboratories Method of manufacturing an aseptically sterilized package containing a liquid nutritional product
US6103764A (en) 1997-11-07 2000-08-15 Iowa State University Research Foundation, Inc. Method for increasing the aerobic capacity of muscle
AUPP327198A0 (en) 1998-04-30 1998-05-21 Northfield Laboratories Pty Ltd A food composition and method of using same
US6475539B1 (en) * 1998-05-07 2002-11-05 Abbott Laboratories Nutritionally complete low pH enteral formula
JP4175698B2 (ja) 1998-06-19 2008-11-05 サントリー株式会社 新規なトリグリセリド及びそれを含む組成物
US6031000A (en) 1998-06-23 2000-02-29 Iowa State University Research Foundation, Inc. Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use
ES2235499T3 (es) 1998-07-30 2005-07-01 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Uso de derivados de propionil l-carnitina y de acetil l-carnitina en la preparacion de medicamentos con actividad anticancerigena.
KR20000019716A (ko) 1998-09-15 2000-04-15 박호군 바이오플라보노이드 화합물을 포함하는 혈당 강하용 조성물
US5976550A (en) 1998-11-20 1999-11-02 Engel; Peter H. Dietary food supplement
US20010008641A1 (en) 1998-11-25 2001-07-19 R. Douglas Krotzer Nutritionally active composition for bodybuilding
US6227261B1 (en) 1998-12-24 2001-05-08 Abbott Laboratories Method and apparatus for the addition of sterile liquid to an aseptic system
US6294206B1 (en) 1999-04-09 2001-09-25 Abbott Laboratories Powdered human milk fortifier
US6517775B1 (en) 1999-07-26 2003-02-11 Abbott Laboratories Sterilant monitoring assembly and apparatus and method using same
US6291525B1 (en) 1999-09-08 2001-09-18 Iowa State University Research Foundation, Inc. Method for improving a human's perception of his emotional state
WO2001028356A2 (en) 1999-10-18 2001-04-26 Muscletech Research And Development Inc. Food supplement for increasing lean mass and strength
GB9929919D0 (en) * 1999-12-17 2000-02-09 Hannah Research Inst The Calcium phosphate nanoclusters and their applications
CZ20022927A3 (cs) 2000-02-01 2003-06-18 Muscletech Research And Development Inc. Doplňky stravy založené na alfa-lipoové kyselině pro zvýšení čisté svalové hmoty a síly
US6365218B1 (en) 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US6521591B1 (en) 2000-02-10 2003-02-18 N.V. Nutricia Pharmaceutical composition for muscular anabolism
US7250397B2 (en) 2000-02-23 2007-07-31 Zealand Pharma A/S Antiarrhythmic peptides
CA2404799C (en) 2000-04-06 2007-08-07 Conlinco, Inc. Conjugated linoleic acid compositions
JP4625156B2 (ja) 2000-04-10 2011-02-02 イーエヌ大塚製薬株式会社 癌化学療法に伴う副作用軽減剤
US6420342B1 (en) 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
US20050106219A1 (en) 2000-05-30 2005-05-19 Karlheinz Bortlik Primary composition comprising a lipophilic bioactive compound
US6592878B2 (en) 2000-08-03 2003-07-15 North Carolina State University Enhancement of development of oviparous species by in ovo feeding
EP1326502B1 (de) 2000-08-29 2005-05-18 Lonza Ag Verfahren zur herstellung einer granulierbaren mischung und carnitin-magnesium-hydroxycitrat
EP1198991B1 (en) 2000-10-20 2012-12-19 Nutriz N.V: Non-dairy products derived from rice
NZ521894A (en) 2001-02-15 2006-08-31 Adeka Corp Products containing beta-glucan
JP3735070B2 (ja) 2001-03-26 2006-01-11 花王株式会社 容器詰乳化飲料
US6620427B2 (en) 2001-04-24 2003-09-16 Abbott Laboratories Method for improving bone mineralization
US20030021877A1 (en) 2001-06-13 2003-01-30 Cain Frederick William Micronised fat particles
CN1231137C (zh) * 2001-07-18 2005-12-14 Dsmip资产有限公司 乳类蛋白质水解的方法
DE10145818C1 (de) 2001-09-17 2002-10-10 Alfill Engineering Gmbh & Co K Sterilisiervorrichtung mit H202-Verdampfer
DE10146594A1 (de) 2001-09-21 2003-04-10 Solvay Interox Gmbh Stabilisiertes Wasserstoffperoxid
JP2003137790A (ja) 2001-11-01 2003-05-14 Mie Kariyou Kk β−２，１（β２→β１）結合連鎖フラクトースオリゴマーを含有するフラクトオリゴ糖を有効成分とする医薬
GB2381451A (en) 2001-11-01 2003-05-07 New Technology Res Ltd Pharmaco-dietary preparation having nutrition-supplementing and nutrition-enhancing effect
ATE369045T1 (de) * 2001-11-26 2007-08-15 Nestec Sa Lagerstabiles nahrungsmittelprodukt enthaltend molkenprotein, verfahren zu seiner herstellung und verwendung
US6811801B2 (en) 2001-12-12 2004-11-02 Abbott Laboratories Methods and compositions for brightening the color of thermally processed nutritionals
WO2003049832A1 (en) 2001-12-12 2003-06-19 Martek Biosciences Boulder Corp. Extraction and winterization of lipids from oilseed and microbial sources
DE10163676A1 (de) 2001-12-21 2003-07-10 Phenion Gmbh & Co Kg Verwendung von Hyperforin oder Extrakten aus Johanniskraut gegen anaphylaktische Schockzustände oder Osteoporose
US7168581B2 (en) 2001-12-21 2007-01-30 Rexam Medical Packaging Inc. Closure for a retort processed container having a peelable seal
ATE438621T1 (de) 2002-04-23 2009-08-15 Aventis Pharma Inc 3-(substitutierte amino)-1h-indole-2- carbonsäureester und 3-(substitutierte amino)- benzoäbüthiophen-2-carbonsäureester verbindungen als inhibitoren der interleukin-4 genexpression
SE0201581D0 (sv) 2002-05-29 2002-05-29 Scandinavian Biotechnology Res New improved acyltransferase
WO2004002232A1 (en) 2002-06-28 2004-01-08 Theuer Richard C Fat compositions for infant formula and methods therefor
US20040220266A1 (en) * 2002-09-09 2004-11-04 Wiley David B. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20040048925A1 (en) 2002-09-09 2004-03-11 Wiley David B. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20040106678A1 (en) 2002-09-17 2004-06-03 Dobbins Thomas A Compositions for the parenteral administration of calcium and magnesium
WO2004035624A2 (en) 2002-10-14 2004-04-29 Novo Nordisk A/S Glucagon - like peptide - 2 variants
US7445807B2 (en) 2002-10-15 2008-11-04 Western Holdings, Llc Agglomerated granular protein-rich nutritional supplement
CN1307478C (zh) 2003-01-07 2007-03-28 统宝光电股份有限公司 降低反射的液晶显示单元构造及其形成方法
GB0301554D0 (en) 2003-01-23 2003-02-26 Molecularnature Ltd Immunostimulatory compositions
US7332178B2 (en) 2003-04-25 2008-02-19 Abbott Laboratories Stable nutritional powder containing ascorbyl palmitate
FR2856596B1 (fr) 2003-06-27 2007-04-27 Bioprojet Soc Civ Nouvelle association medicamenteuse psychiatrique et utilisation d'une antagoniste ou agoniste inverse du recepteur h3 de l'histamine pour preparer un medicament prevenant des effets indesirables de psychotropes.
WO2005035557A2 (en) 2003-10-14 2005-04-21 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Adenylate cyclase in the treatment and/or prophylaxis of immune-medicated disease
IL158555A0 (en) 2003-10-22 2004-05-12 Enzymotec Ltd Human breast milk lipid mimetic as dietary supplement
WO2005060952A1 (en) 2003-12-24 2005-07-07 N.V. Nutricia Compositions comprising pantothenic acid or derivatives thereof and their use for stimulating appetite
EP1750527A1 (en) * 2004-03-11 2007-02-14 Wiley Organics, Inc. Compositions and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
US20050249650A1 (en) 2004-05-07 2005-11-10 Fmc Technologies, Inc. Immersion retort
DE102004036047A1 (de) 2004-07-24 2006-02-23 Bioghurt Biogarde Gmbh & Co. Kg Physiologisch aktive Zusammensetzung
US20060024385A1 (en) 2004-07-27 2006-02-02 Pedersen Mark A Metabolic capacity enhancing compositions and methods for use in a mammal
ES2355644T5 (es) 2004-09-09 2020-07-15 Nestle Sa Métodos para la preparación de productos nutricionales de calidad mejorada
US8557551B2 (en) 2004-09-10 2013-10-15 Dsm Ip Assets B.V. Compositions and methods for making and modifying oils
JP4262710B2 (ja) 2004-10-15 2009-05-13 株式会社大塚製薬工場 流動食の製造方法
PL371081A1 (pl) 2004-11-08 2006-05-15 Sgp & Sons Ab Preparat farmaceutyczny wpływający na procesy wzrostu i mineralizacji układu kostno-szkieletowego oraz chorób kości i chrząstki wieku dojrzałego u ludzi i zwierząt oraz zastosowanie preparatu farmaceutycznego w procesie wzrostu i mineralizacji układu kostno-szkieletowego oraz chorób kości i chrząstki wieku dojrzałego u ludzi i zwierząt
WO2006058083A2 (en) * 2004-11-24 2006-06-01 Cornell Research Foundation, Inc. Protein and calcium fortification system for clear and opaque beverages
US8067052B2 (en) 2005-02-25 2011-11-29 Siddharth Shastri Nutritional composition and a container for the convenient transport and storage of the nutritional composition
CA2537452C (en) 2005-03-09 2013-12-24 Abbott Laboratories Concentrated human milk fortifier liquid
KR20130136013A (ko) 2005-04-27 2013-12-11 엔지모테크 리미티드 모유 지방 대체물
MX2007013028A (es) 2005-06-06 2008-01-11 Bristol Myers Squibb Co Formulas infantiles con bajo contenido de fitato.
EP1921928A1 (en) * 2005-08-26 2008-05-21 Nestec S.A. Nutrition for obese patients
EP1762147A1 (en) 2005-09-09 2007-03-14 Primalac Private Foundation Nutritional concentrate for infants
MY147363A (en) 2005-09-20 2012-11-30 Nestec Sa Water dispersible composition and method for preparing same
CA2625338A1 (en) 2005-10-07 2007-06-14 Ocean Nutrition Canada Ltd. Salts of fatty acids and methods of making and using thereof
WO2007056176A2 (en) 2005-11-03 2007-05-18 Southwest Immunology, Inc. Compositions for preventing and reducing delayed onset muscle soreness
ES2548432T3 (es) * 2005-12-19 2015-10-16 Abbott Laboratories Uso de beta-hidroxi-beta-metilbutirato para modular el desequilibrio en la producción de citoquinas de tipo 1 y tipo 2
BRPI0706795A2 (pt) 2006-01-31 2011-04-05 Nestec Sa composição nutricional para bebês com baixo peso de nascimento
US20070219146A1 (en) 2006-02-06 2007-09-20 Sunil Bhaskaran Synergistic Pharmaceutical And/Or Neutraceutical Flavanoid Composition For Management Of Diabetes Mellitus
WO2007098092A2 (en) 2006-02-21 2007-08-30 Nutrijoy, Inc. Food and beverage products with improved taste impressions
BRPI0712187A2 (pt) 2006-06-05 2012-03-06 Liqui-Box Canada Inc. processo e aparelho para formar uma bolsa de espaÇo confinado mÍnimo
MX2008015856A (es) * 2006-06-12 2009-01-12 Nestec Sa Concentrados de leche auto-estables para preparar bebidas a base de leche acidificadas.
US20080119552A1 (en) 2006-11-17 2008-05-22 Novus International Inc. Matrix-embedded compositions having organic acids and fatty acids
US20080194407A1 (en) * 2007-02-14 2008-08-14 Ashmead H Dewayne High nitrogen containing chelate compositions suitable for plant delivery
CA2685031A1 (en) 2007-03-19 2008-09-25 Atm Metabolics Lllp Composition for treating diabetes and metabolic disorders with quercetin, myrcetin and chlorogenic acid
US20090110674A1 (en) * 2007-10-24 2009-04-30 Loizou Nicos C Health supplement
US8029830B2 (en) 2008-04-18 2011-10-04 Nuvocare Health Services Inc. Composition and method for promoting internal health and external appearance
CN101574146B (zh) 2008-05-07 2012-06-13 北京康比特体育科技股份有限公司 一种含有hmb的运动营养补剂
CA2723441A1 (en) 2008-05-21 2009-11-26 Stokely-Van Camp, Inc. Milk-based recovery beverage
US20100074969A1 (en) 2008-09-19 2010-03-25 Unicity International, Inc. Method of controlling blood sugar levels, insulin levels, cholesterol levels, body fat levels, and body weight by administering a nutrient fiber matrix
CA2746420C (en) * 2008-12-09 2019-11-12 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
JP2009155336A (ja) 2009-03-31 2009-07-16 Tsujido Chemical Corp 治療剤
JP2009159983A (ja) * 2009-04-13 2009-07-23 Tsujido Chemical Corp 食品組成物
CN101569412B (zh) 2009-06-01 2012-12-05 北京康比特体育科技股份有限公司 一种运动营养补剂及其应用
US20090312419A1 (en) * 2009-08-12 2009-12-17 Kneller Bruce W CREATINE -ßALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE
CN101703246A (zh) 2009-11-17 2010-05-12 卢惠强 一种运动补充组合物
PL217815B1 (pl) 2009-12-14 2014-08-29 Olimp Lab Spółka Z Ograniczoną Odpowiedzialnością Napój izotoniczny z chelatami
MX2012008778A (es) 2010-01-29 2012-09-07 Abbott Lab Polvos nutricionales que comprenden hmb secado por aspersion.
JP5892948B2 (ja) * 2010-01-29 2016-03-23 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ カルシウムｈｍｂを含む栄養エマルジョン
BR112012018174A2 (pt) * 2010-01-29 2019-08-27 Abbott Lab líquidos nutricionais embalados assepticamente compreendendo hmb.
CN102711525B (zh) 2010-01-29 2015-03-11 雅培制药有限公司 包含hmb钙和可溶蛋白的营养乳液
ES2533357T3 (es) * 2010-01-29 2015-04-09 Abbott Laboratories Líquidos nutricionales envasados en plástico que comprenden HMB
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液
SG191315A1 (en) 2010-12-22 2013-07-31 Abbott Lab Nutritional products comprising calcium beta-hydroxy-beta methylbutyrate and conjugated linoleic acid
WO2012097064A1 (en) 2011-01-13 2012-07-19 Abbott Laboratories Nutritional compositions and methods for controlling blood glucose
SG192692A1 (en) 2011-02-07 2013-09-30 Abbott Lab Nutritional products comprising beta-hydroxy-beta-methylbutyrate
CN103347406B (zh) 2011-02-17 2015-08-05 雅培制药有限公司 使用β-羟基-β-甲基丁酸盐改善脑部发育和认知功能的方法
CA2737972A1 (en) 2011-04-07 2012-10-07 Abbott Laboratories Aseptically packaged nutritional concentrate

Also Published As

Publication number Publication date
BR112012031183A2 (pt) 2015-09-08
CA2801339A1 (en) 2011-12-15
JP2013528060A (ja) 2013-07-08
ES2535389T3 (es) 2015-05-11
MX2012014346A (es) 2013-01-22
CN103096736B (zh) 2015-10-07
US9521859B2 (en) 2016-12-20
US20110305799A1 (en) 2011-12-15
AR081872A1 (es) 2012-10-24
EP2442676A1 (en) 2012-04-25
SG185806A1 (en) 2013-01-30
PH12012502318A1 (en) 2022-03-21
TWI526161B (zh) 2016-03-21
CN103096736A (zh) 2013-05-08
WO2011156238A1 (en) 2011-12-15
CA2801339C (en) 2016-07-19
TW201204268A (en) 2012-02-01
EP2442676B1 (en) 2015-03-04

Similar Documents

Publication Publication Date Title
JP5848756B2 (ja) カルシウムｈｍｂおよび可溶性タンパク質を含む実質的に清澄な栄養液体
CN104643067B (zh) 包含hmb钙和可溶蛋白的营养乳液
JP5892948B2 (ja) カルシウムｈｍｂを含む栄養エマルジョン
US20130337144A1 (en) Nutritional products comprising calcium hmb and conjugated linoleic acid
HK1178028B (en) Nutritional emulsions comprising calcium hmb
HK1165228B (en) Nutritional emulsions comprising calcium hmb and soluble protein

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140528

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140528

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20141009

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20141111

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150206

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150508

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20150513

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150513

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20151104

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20151127

R150 Certificate of patent or registration of utility model

Ref document number: 5848756

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees